Vistagen Therapeutics, Inc.
VTGN • NASDAQ • Stock Fundamentals
Vistagen Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Shawn K. Singh, with a market cap of $22.7M.
Market Cap$22.7M
Employees37.0
CEOShawn K. Singh
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsFeb 12, 2026 · 4 months 2 days agoQ4 2025
View reportNext EarningsJul 1, 2026 · In 2 weeksAfter Market Close · Q2 2026
Financials
Based on Q4 2025 filing
Vistagen Therapeutics, Inc. FAQ
Common questions about Vistagen Therapeutics, Inc.
Vistagen Therapeutics, Inc. (VTGN) has a market capitalization of $22.7M and trades on NASDAQ.
Vistagen Therapeutics, Inc. has approximately 37 employees.